202 related articles for article (PubMed ID: 12000834)
1. Functional characterisation of mycobacterial DNA gyrase: an efficient decatenase.
Manjunatha UH; Dalal M; Chatterji M; Radha DR; Visweswariah SS; Nagaraja V
Nucleic Acids Res; 2002 May; 30(10):2144-53. PubMed ID: 12000834
[TBL] [Abstract][Full Text] [Related]
2. Functional interactions between gyrase subunits are optimized in a species-specific manner.
Weidlich D; Klostermeier D
J Biol Chem; 2020 Feb; 295(8):2299-2312. PubMed ID: 31953321
[TBL] [Abstract][Full Text] [Related]
3. A complex of DNA gyrase and RNA polymerase fosters transcription in Mycobacterium smegmatis.
Gupta R; China A; Manjunatha UH; Ponnanna NM; Nagaraja V
Biochem Biophys Res Commun; 2006 May; 343(4):1141-5. PubMed ID: 16579974
[TBL] [Abstract][Full Text] [Related]
4. gyrB-225, a mutation of DNA gyrase that compensates for topoisomerase I deficiency: investigation of its low activity and quinolone hypersensitivity.
Heddle JG; Lu T; Zhao X; Drlica K; Maxwell A
J Mol Biol; 2001 Jun; 309(5):1219-31. PubMed ID: 11399091
[TBL] [Abstract][Full Text] [Related]
5. Effect of different classes of inhibitors on DNA gyrase from Mycobacterium smegmatis.
Chatterji M; Unniraman S; Mahadevan S; Nagaraja V
J Antimicrob Chemother; 2001 Oct; 48(4):479-85. PubMed ID: 11581225
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the ATPase activity of the Escherichia coli RecG protein reveals that the preferred cofactor is negatively supercoiled DNA.
Slocum SL; Buss JA; Kimura Y; Bianco PR
J Mol Biol; 2007 Mar; 367(3):647-64. PubMed ID: 17292398
[TBL] [Abstract][Full Text] [Related]
7. Active-site residues of Escherichia coli DNA gyrase required in coupling ATP hydrolysis to DNA supercoiling and amino acid substitutions leading to novobiocin resistance.
Gross CH; Parsons JD; Grossman TH; Charifson PS; Bellon S; Jernee J; Dwyer M; Chambers SP; Markland W; Botfield M; Raybuck SA
Antimicrob Agents Chemother; 2003 Mar; 47(3):1037-46. PubMed ID: 12604539
[TBL] [Abstract][Full Text] [Related]
8. A monoclonal antibody that inhibits mycobacterial DNA gyrase by a novel mechanism.
Manjunatha UH; Maxwell A; Nagaraja V
Nucleic Acids Res; 2005; 33(10):3085-94. PubMed ID: 15930158
[TBL] [Abstract][Full Text] [Related]
9. Dissection of the nucleotide cycle of B. subtilis DNA gyrase and its modulation by DNA.
Göttler T; Klostermeier D
J Mol Biol; 2007 Apr; 367(5):1392-404. PubMed ID: 17320901
[TBL] [Abstract][Full Text] [Related]
10. Binding and Hydrolysis of a Single ATP Is Sufficient for N-Gate Closure and DNA Supercoiling by Gyrase.
Hartmann S; Gubaev A; Klostermeier D
J Mol Biol; 2017 Nov; 429(23):3717-3729. PubMed ID: 29032205
[TBL] [Abstract][Full Text] [Related]
11. Distinct subunit architecture and assembly pattern of DNA gyrase from mycobacteria.
Faheem I; Gupta R; Nagaraja V
Mol Microbiol; 2023 Jun; 119(6):728-738. PubMed ID: 37190861
[TBL] [Abstract][Full Text] [Related]
12. The acidic C-terminal tail of the GyrA subunit moderates the DNA supercoiling activity of Bacillus subtilis gyrase.
Lanz MA; Farhat M; Klostermeier D
J Biol Chem; 2014 May; 289(18):12275-85. PubMed ID: 24563461
[TBL] [Abstract][Full Text] [Related]
13. ATP binding controls distinct structural transitions of Escherichia coli DNA gyrase in complex with DNA.
Basu A; Schoeffler AJ; Berger JM; Bryant Z
Nat Struct Mol Biol; 2012 Apr; 19(5):538-46, S1. PubMed ID: 22484318
[TBL] [Abstract][Full Text] [Related]
14. Binding of two DNA molecules by type II topoisomerases for decatenation.
Kumar R; Riley JE; Parry D; Bates AD; Nagaraja V
Nucleic Acids Res; 2012 Nov; 40(21):10904-15. PubMed ID: 22989710
[TBL] [Abstract][Full Text] [Related]
15. Mycobacterium tuberculosis DNA gyrase: interaction with quinolones and correlation with antimycobacterial drug activity.
Aubry A; Pan XS; Fisher LM; Jarlier V; Cambau E
Antimicrob Agents Chemother; 2004 Apr; 48(4):1281-8. PubMed ID: 15047530
[TBL] [Abstract][Full Text] [Related]
16. Evidence for the role of DNA strand passage in the mechanism of action of microcin B17 on DNA gyrase.
Pierrat OA; Maxwell A
Biochemistry; 2005 Mar; 44(11):4204-15. PubMed ID: 15766248
[TBL] [Abstract][Full Text] [Related]
17. Vibrio cholerae ParE2 poisons DNA gyrase via a mechanism distinct from other gyrase inhibitors.
Yuan J; Sterckx Y; Mitchenall LA; Maxwell A; Loris R; Waldor MK
J Biol Chem; 2010 Dec; 285(51):40397-408. PubMed ID: 20952390
[TBL] [Abstract][Full Text] [Related]
18. Mycobacterial DNA gyrase: enzyme purification and characterization of supercoiling activity.
Wu LC; Shahied SI
Arch Biochem Biophys; 1995 Dec; 324(1):123-9. PubMed ID: 7503546
[TBL] [Abstract][Full Text] [Related]
19. Assays, surrogates, and alternative technologies for a TB lead identification program targeting DNA gyrase ATPase.
Humnabadkar V; Madhavapeddi P; Basavarajappa H; Sheikh MG; Rane R; Basu R; Verma P; Sundaram A; Mukherjee K; de Sousa SM
J Biomol Screen; 2015 Feb; 20(2):265-74. PubMed ID: 25300873
[TBL] [Abstract][Full Text] [Related]
20. Mycobacterium tuberculosis DNA gyrase possesses two functional GyrA-boxes.
Bouige A; Darmon A; Piton J; Roue M; Petrella S; Capton E; Forterre P; Aubry A; Mayer C
Biochem J; 2013 Nov; 455(3):285-94. PubMed ID: 23869946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
